Forecast

There is no analyst data available for this company.

News Go to news feed

SUGI PHARMACY to report quarterly results on April 9; analysts see significantly lower EPS, revenue rises

SUGI PHARMACY will release figures for the quarter ended February 28, 2026 on April 9, 2026. Three analysts expect an average EPS of 17.45 JPY (prior year: 36.65 JPY). Six analysts forecast revenue of 258.54 billion JPY, up 6.22% versus the same quarter last year. For the just-ended fiscal year, seven analysts' average estimates are EPS of 248.14 JPY (prior year: 141.96 JPY) and revenue of 1,008.86 billion JPY (prior year: 878.02 billion JPY). » More on finanzen.net
SUGI PHARMACY to release quarterly results on January 8, analysts see strong profit and revenue growth

SUGI PHARMACY will publish the quarter-end balance sheet for the period to November 30, 2025 on January 8. Three analysts expect EPS of JPY 41.86 per share (+26.31% vs. the prior year) and six analysts forecast revenue of JPY 247.85 billion (+12.25% vs. the prior year). For the current fiscal year, consensus estimates are JPY 246.97 earnings per share and annual revenue of JPY 1,009.77 billion. » More on finanzen.net
SUGI PHARMACY expects higher quarterly profit and revenue

SUGI PHARMACY is expected to announce results for the most recent quarter on 08.01.2026. Three analysts forecast an average EPS of 41.86 JPY versus 33.14 JPY a year earlier, with average revenue of 246.66 billion JPY versus 220.81 billion JPY. For the current fiscal year, the average estimates from ten analysts are earnings per share of 247.30 JPY (prior year 141.96 JPY) and revenue of 1,009.63 billion JPY (prior year 878.02 billion JPY). » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2025, Sugi has already paid €0.20 in dividends. The last payout was in November 2025.

Financials

In the last quarter, Sugi had revenue of €1.46B and net profit of €37.17M

(EUR)	May 2026	YoY
Revenue	1.46B	3.07%
Gross profit	448.88M	2.94%
Net profit	37.17M	71.37%
EBITDA	94.71M	1.23%

Fundamentals

Metric	Value
Market capitalization	€2.77B
Number of shares	372.11M
52-week high/low	€11.13 - €7.15
Dividend yield	1.14%
Dividends TTM	€0.0847
Beta	0.28
P/E ratio	15.70
PEG ratio	-0.63
P/B ratio	1.64
P/S ratio	0.48

Company profile

Sugi Holdings Co.,Ltd. betreibt Drogerien in Japan. Darüber hinaus bietet das Unternehmen Krankenpflegedienste und häusliche Pflegedienstleistungen an. Zum 1. Juni 2019 betrieb das Unternehmen 1.190 Filialen. Sugi Holdings Co.,Ltd. wurde 1976 gegründet und hat seinen Hauptsitz in Obu, Japan.